ACAAI 2014 Annual Scientific Meeting (DVD) EXT

NOTE: This course expires Feb. 28, 2017 and credit cannot be claimed past that date.

This online/DVD contains the following select content from the 2014 ACAAI Annual Scientific Meeting. The cost is $299 which includes the DVD and online access.

1. Skin Allergy Conference
2. Literature Review
 
Plenary Sessions
3. Unique Challenges for the Allergist/Immunologist in COPD and Asthma  
4. The Brave New World for the Allergist/Immunologist in Immunotherapy  
5. If You Don’t Know Where You Are Going, You May End Up Somewhere Else / Unique Challenges for the Allergist/Immunologist in Children and Adolescents  
6. My Patient Is Allergic to My Treatment: Adverse and Allergic Responses to Allergy and Asthma Medications  
7. Healthy Homes and the Allergist/Immunologist  
8. A New Era in the Diagnosis and Treatment of Food Allergy  
 
Symposia
9. Asthma and COPD: What Is the Difference? 
10. Emerging Approaches Related to Allergy Treatment 

Accreditation

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 27.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

If you have purchased this program and need your code for online access, please send an email to: support@blueskybroadcast.com  SUBJECT: Access Code for 2014 ACAAI Annual Meeting". Include your  contact information and approximate date/year of purchase.

Target Audience

  • All practicing allergists/immunologists
  • Fellows in allergy/immunology training programs
  • Primary care physicians who care for allergy patients
  • Allied health professionals in the field of allergy and immunology

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Identify major advances in key areas of cutting edge research in immunologic mechanisms and allergic responses, including anaphylaxis and pathophysiology of
  • the upper airways, lungs, eyes, skin and gastrointestinal tract
  • Demonstrate knowledge of basic processes linking molecular and cellular biology and genetics with allergic pathophysiology and immunodeficiency
  • Translate emerging clinical science principles to clinical practice in patients with allergic and immunologicdiseases
  • Evaluate and implement state-of-the-art diagnostic and therapeutic strategies for treating patients with allergicand immunologic diseases
  • Explain the impact of environmental exposures and external influences on patients with allergic disorders
Additional information
Disclosure: 

Disclosure:

Course summary
Course opens: 
03/01/2015
Course expires: 
02/28/2017
Cost:
$0.00

Disclosure Policy and Disclosures
As required by the Accreditation Council for ContinuingMedical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors,moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activitymust disclose all relevant financial relationships with any commercial interest that have occurred within the past 12months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationshipsmust also informthe learners that no relevant financial relationships exist. Learnersmust also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in relatedmaterials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the programcontents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified conflicts of interest have been resolved.

Ignacio J. Ansotegui, MD, PhD
Consultant/Advisory Board: Bial, Faes Farma; Speaker: Bial, Faes Farma, Pfizer, Sanofi

Marcella R. Aquino, MD, FACAAI
Research Grant: Genentech, Merck

Noga Askenazi MD, FACAAI
Speaker: Johnson & Johnson

Amal H. Assa'ad, MD, FACAAI
Research Grant: Cephalon, DBV Technologies, GlaxoSmithKline

Lisa A. Beck, MD
Consultant/Advisory Board: Celgene, MedImmune, Novartis, Regeneron; Honorarium: Array BioPharma, Sanofi; Speaker: Wyeth

Gregory W. Bensch, MD, FACAAI
Research Grant: Meda

William E. Berger, MD, MBA, FACAAI
Consultant/Advisory Board: AstraZeneca, Genentech, GlaxoSmithKline, Meda, Merck, Novartis, Sanofi, Teva; Speaker: Alcon, Allergen, AstraZeneca, Circassia, Genentech, McNeil, Meda, Mylan, Teva; Honorarium: Alcon, Allergen, AstraZeneca, Genentech, GlaxoSmithKline, Meda, Merck, Mylan, Novartis, Ono Pharma, Sanofi, Sunovion, Teva

David I. Bernstein, MD, FACAAI
Consultant/Advisory Board: Circassia, Genentech, Merck; Speaker: Merck; Honorarium: Circassia, Merck; Research Grant: Boehringer Ingelheim, Circassia, Genentech, GlaxoSmithKline, Janssen, Merck, Pfizer, Sanofi, Teva    

Leonard Bielory, MD, FACAAI
Consultant/Advisory Board: Allergan, Bausch & Lomb, Merck, Pharmacal; Speaker/ Honorarium: Allergan, Bausch & Lomb, Merck; Research Grant: Allergan, EPA

Mark Boguniewicz, MD, FACAAI
Consultant/Advisory Board: Celgene, Unilever; Research Grant: Anacor, Merck

Don A. Bukstein, MD, FACAAI
Consultant/Advisory Board: Circassia, Novartis; Speaker: Alcon, AstraZeneca, Genentech, Meda,   Merck, Novartis; Research Grant: Circassia

A. Wesley Burks, MD, FACAAI
Consultant/Advisory Board: DOW Agro Sciences, Dynavax Technologies, Genalyte, GLG Research, Hycor Biomedical, Medline Industries, Merck, Nordic Biotech Advisors, Nutricia North America, Perrigo, Regeneron, Perosphere; Honorarium: Mylan Specialty; Research Grant: Hycor Biomedical, Allertein Therapeutics, Mast Cell Pharmaceuticals

William W. Busse, MD, FACAAI
Consultant/Advisory Board: Genentech, GlaxoSmithKline, Novartis, Roche; DSMB: Boston Scientific, Genentech, Icon  

Warner W. Carr, MD, FACAAI
Consultant/Advisory Board: Aerocrine, Alcon, Allergan, AstraZeneca, Meda, Merck, Mylan, Teva; Speaker: Aerocrine, Allergan, AstraZeneca, Meda, Mylan, Teva; Honorarium: Aerocrine, Alcon, Allergan, AstraZeneca, Meda, Mylan, Teva; Clinical Research: Merck, Novartis, Novum, Sanofi 

Mariana C. Castells, MD, PhD, FACAAI
Consultant/Advisory Board: Merck, Sanofi; Research Grant: National Institutes of Health (NIH)

Bradley E. Chipps, MD, FACAAI
Consultant/Advisory Board, Honorarium: AstraZeneca, Genentech, GlaxoSmithKline, Meda, Merck, Mylan Specialty, Novartis, Sunovion; Speaker: AstraZeneca, Genentech, GlaxoSmithKline, Meda, Merck, Novartis, Sunovion 

Peter S. Creticos, MD
Consultant/Advisory Board: Circassia, Greer; Speaker: Merck; Honorarium, Research Grant: Circassia, Greer, Merck

Chitra Dinakar, MD, FACAAI
Speaker, Honorarium: Aerocrine, GlaxoSmithKline, Teva  

Stephen R. Durham, MD
Consultant/Advisory Board: Circassia, Leti, Merck; Research Grant: ALK

Mark S. Dykewicz, MD, FACAAI
Consultant/Advisory Board, Honorarium: Merck; Research Grant: Novartis

Stanley M. Fineman, MD, MBA, FACAAI
Consultant/Advisory Board: Mylan; Speaker: Aerocrine, AstraZeneca, Genentech, Meda, Mylan, Novartis; Research Grant: Genentech, Mylan, Novartis

Michael B. Foggs, MD, FACAAI
Consultant/Advisory Board: AstraZeneca, Boehringer Ingelheim, Boston Scientific, GlaxoSmithKline, Hycor, Meda, Merck, Mylan, Sunovion; Speaker: AstraZeneca, Boston Scientific, GlaxoSmithKline, Merck; Honorarium: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hycor, Meda

Luz S. Fonacier, MD, FACAAI
Speaker: Baxter; Honorarium: Genentech; Research Grant: Baxter, Dyax, Genentech, Merck

Joseph W. Fowler, MD, Jr., FACAAI
Consultant/Advisory Board, Speaker, Research Grant: SmartPractice

Pinkus Goldberg, MD
Consultant/Advisory Board: Allergan; Speaker: Genentech, Meda, Merck, Mylan, Novartis; Research Grant: Circassia, Genentech, GlaxoSmithKline, Meda, Merck, Novartis, Teva

Richard G. Gower, MD, FACAAI
Consultant/Advisory Board: CSL Behring, Dyax, Genentech, HollisterStier, Mylan, Novartis, Roche, Shire, Teva; Speaker: CSL Behring, Mylan, Shire, Teva; Honorarium: CSL Behring, Genentech, Mylan, Novartis, Roche, Shire, Teva; Research Grant: AstraZeneca, Circassia, CSL Behring, Eli Lilly, Genentech, GlaxoSmithKline, Mylan, Novartis, Pearl, Roche, Shire, Teva

Matthew Greenhawt, MD, MBA, MSc
Consultant/Advisory Board: BioStrategies, Deerfield Industires, Huron Consulting, Nutricia; Speaker: Nutricia; Research Grant: National Institutes of Health (NIH), University of Michigan Food Allergy Center 

Vivian Hernandez-Trujillo, MD, FACAAI
Consultant/Advisory Board, Speaker: Baxter, CSL Behring, Merck, Sanofi 

Sharon E. Jacob, MD
Consultant/Advisory Board: Johnson & Johnson; Research Grant: SmartPractice USA

Lewis J. Kanter, MD, FACAAI
Speaker: Alcon, AstraZeneca, Teva

Rohit K. Katial, MD, FACAAI
Consultant/Advisory Board, Speaker, Honorarium: Teva

David A. Khan, MD, FACAAI
Speaker, Honorarium: Baxter, Genentech

Phillip L. Lieberman, MD, FACAAI
Consultant/Advisory Board: Genentech, Merck; Speaker: Genentech, Meda, Merck, Teva

Todd A. Mahr, MD, FACAAI
Consultant/Advisory Board: Meda, Mylan, Sanofi, Teva; Speaker, Honorarium: Aerocrine, Genentech, GlaxoSmithKline, Meda, Mylan, Sanofi, Teva; Research Grant: Genentech, GlaxoSmithKline

Lyndon Mansfield, MD, FACAAI
Consultant/Advisory Board: Genentech, Speaker: Sunovion, Teva

Anthony Montanaro, MD, FACAAI
Research Grant: Circassia, Genentech, GlaxoSmithKline, Merck, Novartis, Pulmagen Therapeutics, Teva

Harold S. Nelson, MD, FACAAI
Consultant/Advisory Board: Circassia, Merck; Research Grant: Circassia; DSMB: Pearl

Anna H. Nowak-Wegrzyn, MD, FACAAI
Consultant/Advisory Board: Merck, Nestle, Stallergenes; Speaker: Merck, Thermo Fisher Scientific; Research Grant: Food Allergy Research and Education (FARE), National Institute of Allergy and Infectious Diseases/Immune Tolerance Network (NIAID/ITN), Nutricia

Maeve E. O'Connor, MD, FACP, FACAAI
Consultant/Advisory Board: Greer, Meda, Merck, Mylan, Sunovion, Teva; Speaker: Greer, Meda, Merck, Mylan, Sunovion, Thermo Fisher Scientific, Teva

Reynold A. Panettieri, Jr., MD
Consultant/Advisory Board: AstraZeneca, Gilead, Johnson & Johnson, Merck, Teva; Research Grant: AstraZeneca, Gilead, Johnson & Johnson, Merck, Roche, Sanofi

Stephen P. Peters, MD
Consultant/Advisory Board: Aerocrine, Airsonett AB, Array Biopharma, AstraZeneca, Boehringer Ingelheim, Experts in Asthma, GlaxoSmithKline, Merck, Ono, Pfizer, PPD Development, Quintiles, Saatchi & Saatchi, Sunovion, Targacept, Teva; Speaker: Merck; Research/Research Grants: NHLBI, American Lung Association; Actelion, Amgen, AstraZeneca, Boehringer Ingelheim, Centocor,  Genentech, GlaxoSmithKline, Forest, MedImmune, Novartis, Sanofi, Teva

Jay M. Portnoy, MD, FACAAI
Speaker, Honorarium: Mylan, Thermo Fisher Scientific

Marc A. Riedl, MD, MS
Consultant/Advisory Board: Baxter, BioCryst, CSL Behring, Dyax, Salix, Shire; Speaker: Baxter, CSL Behring, Dyax, Shire; Research Grant: Biocryst, CSL Behring, Dyax, Salix, Shire

Lanny J. Rosenwasser, MD, FACAAI
Consultant/Advisory Board: National Heart Lung Blood Institute (NHLBI AsthmaNet), Circassia, Regeneron, Sanofi

John M. Routes, MD, FACAAI
Research Grant: Baxter 

Hugh A. Sampson, MD, FACAAI
Consultant/Advisory Board: Allertein Therapeutics, Danone, MedImmune, Regeneron; Speaker: Allertein Therapeutics 

Mario Sanchez-Borges, MD
Consultant/Advisory Board: Genentech, Novartis; Speaker: FAES Farma 

Charles J. Siegel, MD, FACAAI
Consultant/Advisory Board: Meda, Teva; Speaker, Honorarium: Alcon, Meda, Teva

Brett E. Stanaland, MD
Speaker: Meda 

Gary C. Steven, MD, PhD, FACAAI
Speaker: Merck, Novartis, Teva; Research Grant: Merck, AstraZeneca, Circassia, Genentech, Mylan, Novartis, Novum, Optinose, Concentric, Pulmagen, GlaxoSmithKline, Teva

James L. Sublett, MD, FACAAI
Consultant/Advisory Board: Aerocrine, Asthmapolis, Genentech, GlaxoSmithKline, Meda, Merck, Sunovion, Teva; Speaker: GlaxoSmithKline, Merck, Sunovion, Teva; Honorarium: Aerocrine, GlaxoSmithKline, Meda, Merck, Sunovion, Teva; Research Grant: Asthmapolis, AstraZeneca, Forest, Genentech; Stock: AllergyZone

Donald P. Tashkin, MD
Consultant/Advisory Board: AstraZeneca, Boehringer Ingelheim, Novartis, Teva; Speaker, Honorarium: AstraZeneca, Boehringer Ingelheim, Meda, Novartis, Teva; Research Grant: Boehringer Ingelheim, Novartis 

Janna M. Tuck, MD, FACAAI
Consultant/Advisory: Advanced Tech, Alrstar, CEL-SCI, ContraVir, InvenSense, Synergy

Dana V. Wallace, MD, FACAAI 
Consultant/Advisory Board: Mylan, Sanofi; Speaker: Meda, Mylan, Sanofi, Sunovion, Teva 

Richard W. Weber, MD, FACAAI
Speaker: Merck; Research Grant: GlaxoSmithKline

Matthew J. Zirwas, MD
Consultant/Advisory Board: SmartPractice, Sun Products, Valeant

The following have no relevant financial relationships to disclose:

Sami L. Bahna, MD, DrPH, FACAAI
Monica Bhagat, MD
Alison Bruce, MD
Christina Ciaccio, MD, FACAAI
Vesselin Dimov, MD
Alessandro Fiocchi, MD, FACAAI (SC)
Karen A. Freedle, MD, FACAAI
Curtis L. Hedberg, MD, FACAAI
John M. Kelso, MD, FACAAI
Kevin Kennedy, MPH, CIEC
Tao T. Le, MD, MHS, FACAAI
Gerald B. Lee, MD
James T. Li, MD, PhD, FACAAI
Paul J. Maglione, MD, PhD
Bryan L. Martin, DO, FACAAI
Michael Nelson, MD, PhD, FACAAI
Myngoc T. Nguyen, MD, FACAAI
Richard A. Nicklas, MD, FACAAI
Mark T. O'Hollaren, MD, FACAAI
Ruby U. Pawankar, MD, PhD, FRCP
Wanda Phipatanakul, MD, MS, FACAAI
Joram S. Seggev, MD, FACAAI
David R. Weldon, MD, FACAAI
Robert A. Wood, MD

Commercial Supporters

This activity is supported by independent educational grants from the following commercial supporters:

ALK, Inc.: Supporter of FIT Travel Grants.

AstraZeneca: Supporter of Workshops W-5 – The Affordable Care Act and Asthma Control… and W-10 – Severe Asthma.

Baxter Healthcare: Supporter of the Saturday symposium on Optimizing Immunoglobulin Replacement Therapy… and a vodcast of the symposium.

BR Surgical, LLC: In-kind support consisting of loaned durable equipment for Workshop W-16 – Hands-On Session in Rhinolaryngoscopy.

Genentech | Novartis: Supporter of FIT Travel Grants.

McNeil Consumer Healthcare: Supporter of FIT Travel Grants.

Meda Pharmaceuticals Inc.: Supporter of the Friday Breakfast Symposium on Turbinates to Terminal Bronchioles: The One Airway Concept and Advancements in the Treatment of Asthmatics.

Merck: Supporter of the Meet the Professor Breakfasts… and the ACAAI Foundation Young Faculty Award.

Mylan Specialty L.P.: Supporter of the FIT Program… FIT Travel Grants… and partial support of the Annual Literature Review.

Shire: Supporter of the Friday Symposium on Hereditary Angioedema: Clinical Case Challenge.

SmartPractice: Partial support of the Thursday Conference on Patch Testing.

Available Credit

Accreditation Period

Course opens: 
03/01/2015
Course expires: 
02/28/2017

Price

Cost:
$0.00
Please login or create an account to take this course.